Atlas Trials

Real World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort

Clinical trial NCT04580381 · COMPLETED

Trial details

NCT number
NCT04580381
Sponsor
University Hospital, Caen
Status
COMPLETED
Study type
OBSERVATIONAL
Multiple Sclerosis, Relapsing-Remitting
Start date
2020-09-01
Primary completion
2021-10-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.